MedPath

Magnesium in depression and anxiety and sleep quality

Phase 3
Recruiting
Conditions
Other functional disturbances following cardiac surgery.
I97.1
Registration Number
IRCT20200523047556N1
Lead Sponsor
Bagheiat-allah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Age less than 70 years
Candidate for coronary artery bypass graft surgery
No atrial fibrillation (normal sinus)
No nausea and vomiting
No liver and kidney failure
No history of stroke or cerebral ischemic attack in one month

Exclusion Criteria

No willingness to participate in the study
Emergency surgery
Acute renal failure during the study
Respiratory after surgery and the need for re-intubation inside the chip
Chronic diarrhea
Sensitivity to supplements
History of sleep disorders, anxiety and depression

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sleep quality. Timepoint: Measuring the quality of sleep before prescribing magnesium supplements the day after surgery and the day of discharge from the hospital. Method of measurement: Pittsburgh questionnaire.;Anxiety. Timepoint: Measuring the anxiety and before prescribing magnesium supplements the day after surgery and the day of discharge from the hospital. Method of measurement: Anxiety Questionnaire.;Depreesion. Timepoint: Measuring depression before prescribing magnesium supplements the day after surgery and the day of discharge from the hospital. Method of measurement: Depreesion Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath